Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: A case report

Clinical Medicine Insights: Case Reports

Volumn 6, Issue , 2013, Pages 15-21

  Farsalinos, Konstantinos E ^a   Romagna, Giorgio ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b Verbania Fondotoce   (Italy)

Author keywords

Chronic idiopathic neutrophilia; Electronic cigarette; Inflammation; Smoking; Smoking cessation

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; NICOTINE PATCH; ROSUVASTATIN; SIMVASTATIN; VARENICLINE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CASE REPORT; CHRONIC IDIOPATHIC NEUTROPHILIA; HUMAN; HYPERLIPIDEMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; NEUTROPHILIA; NICOTINE REPLACEMENT THERAPY; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 84873157114     PISSN: 11795476     EISSN: None     Source Type: Journal    
DOI: 10.4137/CCRep.S11175     Document Type: Article

References (25)

1. Tonstad S, Johnston JA. Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil. 2006;13(4): 507-514.
2. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519-1528.
3. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control. 2006;15(6):472-480.
4. Lightwood JM, Glantz SA. Short-term Economic and Health Benefits of Smoking Cessation. Circulation. 1997;96(4):1089-1096.
5. Taylor DH, Hasselblad V, Henley SJ, Thun MJ, Sloan FA. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92(6):990-996.
6. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29-38.
7. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221-229.
8. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Red J. 2006;3:37.
9. Weir AB, Lewis JB Jr, Arteta-Bulos R. Chronic idiopathic neutrophilia: experience and recommendations. South Med J. 2011;104(7):499-504.
10. Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet. 1971;298(7725):632-634.
11. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290(23):1275-1278.
12. Imano H, Sato S, Kitamura A, et al. Leukocyte count is an independent predictor for risk of acute myocardial infarction in middle-aged Japanese men. Atherosclerosis. 2007;195(1):147-152.
13. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. E-cigarette awareness, use, and harm perceptions in US adults. Am J Public Health. 2012;102(9):1758-1766.
14. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward of a repeat of past mistakes? J Public Health Policy. 2011;32:16-31.
15. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786.
16. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as smoking-cessation tool: results of an online survey. Am J Prev Med. 2011;40(4):472-475.
17. Romagna G, Allifranchini E, Bocchieto E, Todeshi S, Esposito M, Farsalinos K. Cytotoxicity of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-Life project): comparison with tobacco smoke extract [abstract]. [http://www.srnteurope.org/assets/Abstract-Book-Final.pdf.] Poster RRP17. 14th Annual Meeting of the Society for Research on Nicotine and Tobacco, Helsinki; 2012 (Accessed Nov, 2012).
18. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette. Chest. 2012;141(6):1400-1406.
19. Flouris AD, Poulianiti KP, Chorti MS, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol. 2012;50(10):3600-3603.
20. Farsalinos K, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes [abstract]. Eur Heart J. 2012;33(Suppl):203.
21. Gonçalves RB, Coletta RD, Silvério KG, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res. 2011; 60(5):409-424.
22. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731-1737.
23. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167-2176.
24. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. N Engl J Med. 1997;336(14):973-979.
25. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the third national health and nutrition examination survey. PLoS Med. 2005;2:e160.